In the Cancer Genome Atlas (TCGA) datasets, hepatocellular carcinoma patients who did not have a negative correlation between SIRT6 and miR-122 expression had a better prognosis than those who had a negative correlation [79]. This evidence concerns the gene SIRT6 and hepatocellular carcinoma.